- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03139838
Prognosticating Outcomes and Nudging Decisions With Electronic Records in the ICU Trial (PONDER-ICU)
August 3, 2022 updated by: University of Pennsylvania
Behavioral Economic Approaches to Improve Palliative Care for Critically Ill Patients
This is a pragmatic, stepped-wedge, cluster randomized trial testing the real-world effectiveness of two different electronic health record (EHR) behavioral interventions in improving a number of patient- and family-centered processes and outcomes of care among seriously ill hospitalized patients.
The investigators hypothesize that outcomes can be improved without raising costs by requiring intensive care unit clinicians to (i) document a prognostic estimate and (ii) provide a justification if they choose not to offer patients the option of comfort-oriented care.
To test this hypothesis the investigators will conduct a 33-month trial at 17 intensive care units in 10 hospitals using the same Cerner EHR within Atrium Health System.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The PONDER-ICU trial aims to generate large-scale, experimental evidence regarding the real-world effectiveness of two different electronic health record (EHR) behavioral interventions in improving a number of patient- and family-centered processes and outcomes of care among seriously ill hospitalized patients.
The interventions are designed to increase intensive care unit (ICU) physicians' and advanced practitioners' (physician assistants and nurse practitioners) engagement of critically ill patients and caregivers in discussions about alternative treatment options, including care focused on comfort.
To achieve this goal, the investigators will conduct a 33-month pragmatic, stepped-wedge cluster randomized clinical trial at 17 ICUs within 10 Atrium Health System hospitals.
The investigators hypothesize that outcomes can be improved without raising costs by requiring ICU clinicians to (i) document a prognostic estimate (Intervention A) and (ii) provide a justification if they choose not to offer patients the option of comfort-oriented care (Intervention B).
Approximately 4,750 adult patients (1) with chronic life-limiting illness and receiving continuous mechanical ventilation for ≥48 hours will be enrolled.
Participating hospitals will be randomized into 5 clusters of 2 hospitals each.
Each hospital will first contribute a minimum of 5 months of data collection during usual care in a control phase.
Then, using the step-wedge design, all hospitals will implement the two EHR-based interventions.
The order in which the interventions will be adopted and the timing of adoption at each hospital will both be determined by random assignment.
After 12 months of utilizing Intervention A or Intervention B, each hospital will adopt and implement the second intervention in combination with the other.
By the end of the trial, all hospitals will have utilized the combined interventions for at least 4 months.
The primary outcome is a composite measure of hospital length of stay and mortality.
Secondary outcomes include an array of clinical outcomes, as well as palliative care-related process measures.
Study Type
Interventional
Enrollment (Actual)
3500
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Albemarle, North Carolina, United States, 28001
- Carolinas HealthCare System Stanly
-
Charlotte, North Carolina, United States, 28203
- Carolinas Medical Center
-
Charlotte, North Carolina, United States, 28025
- Carolinas HealthCare System, NorthEast
-
Charlotte, North Carolina, United States, 28207
- Atrium Health CMC-Mercy
-
Charlotte, North Carolina, United States, 28210
- Atrium Health Pineville
-
Charlotte, North Carolina, United States, 28262
- Atrium Health University City
-
Lincolnton, North Carolina, United States, 28092
- Atrium Health Lincoln
-
Monroe, North Carolina, United States, 28112
- Atrium Health Union
-
Morganton, North Carolina, United States, 28655
- Carolinas HealthCare System Blue Ridge-Morganton
-
Shelby, North Carolina, United States, 28150
- Atrium Health Cleveland
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- ≥18 years old; AND
- Admitted to 1 of the 17 participating ICUs; AND
- Receipt of continuous mechanical ventilation for ≥ 48 hours (without interruption); AND
≥ 1 life-limiting illness present on admission (ICD-9/10 code or discrete medical history data from EHR in prior 12 months):
- Chronic obstructive pulmonary disease
- Cirrhosis
- Congestive heart failure
- Dementia (all types)
- End-stage renal disease
- Hematologic malignancy
- Metastatic malignancy
- Motor neuron disease
- Pulmonary fibrosis
- Solid organ malignancy
Exclusion Criteria:
1) Patients younger than 18 years old are excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: EHR-Based Intervention A
Intervention A (Prognostication) will be an EHR-based screen prompt triggered for eligible patients.
The intervention will consist of no more than two questions that can be completed in two minutes or less.
Completion of the prompt will be encouraged but not required, and adherence will be assessed in a minimally intrusive manner.
|
Intervention A will be a prompt for clinicians to document an estimated prognosis for patients at 6 months, and an assessment of predicted functional outcome if expected to survive.
Other Names:
|
|
ACTIVE_COMPARATOR: EHR-Based Intervention B
Intervention B (Accountable Justification) will be an EHR-based screen prompt triggered for eligible patients.
The intervention will consist of no more than two questions that can be completed in two minutes or less.
Completion of the prompt will be encouraged but not required, and adherence will be assessed in a minimally intrusive manner.
|
Intervention B will entail a prompt for clinicians to provide a reason for not offering patients and their families the alternative of care focused entirely on comfort despite recommendations from critical care professional societies to do so for patients at high risk for death or severely impaired functional recovery.
Other Names:
|
|
ACTIVE_COMPARATOR: Combined EHR-Based Intervention (A+B)
Intervention A and B prompts will be combined and triggered for eligible patients simultaneously.
Completion of the prompt will be encouraged but not required, and adherence will be assessed in a minimally intrusive manner.
|
Intervention A will be a prompt for clinicians to document an estimated prognosis for patients at 6 months, and an assessment of predicted functional outcome if expected to survive.
Other Names:
Intervention B will entail a prompt for clinicians to provide a reason for not offering patients and their families the alternative of care focused entirely on comfort despite recommendations from critical care professional societies to do so for patients at high risk for death or severely impaired functional recovery.
Other Names:
|
|
NO_INTERVENTION: Pre-Intervention (Control)
There is no trial-driven approach to care.
All hospitals contribute a minimum of 5 months of outcomes data prior to adopting the intervention.
Pre-specified outcomes data will be electronically extracted for patients meeting eligibility criteria but there will be no attempt to influence delivery of usual care within the hospital.
The length of the control phase will differ at each hospital, dependent on the sequence in which hospitals are assigned to switch to the intervention phase.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Composite Measure: Length of Stay and In-Hospital Mortality
Time Frame: Duration of hospital stay, an expected average of 16 days
|
The primary outcome is a composite measure of hospital length-of-stay and mortality that ranks deaths along the length-of-stay distribution
|
Duration of hospital stay, an expected average of 16 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in code status
Time Frame: Duration of hospital stay, an expected average of 16 days
|
Change in documented code status during hospital admission
|
Duration of hospital stay, an expected average of 16 days
|
|
Initiation of additional forms of life-support
Time Frame: Duration of hospital stay, an expected average of 16 days
|
Initiation of additional form of life-support (e.g.
surgical feeding tube, dialysis) during hospital admission
|
Duration of hospital stay, an expected average of 16 days
|
|
Palliative care consult
Time Frame: Duration of hospital stay, an expected average of 16 days
|
Receipt of palliative care consult during hospital admission
|
Duration of hospital stay, an expected average of 16 days
|
|
Time to palliative care consult
Time Frame: Duration of hospital stay, an expected average of 16 days
|
The number of hours from ICU admission to inpatient palliative care consult
|
Duration of hospital stay, an expected average of 16 days
|
|
Palliative withdrawal of mechanical ventilation
Time Frame: Duration of hospital stay, an expected average of 16 days
|
Palliative withdrawal of mechanical ventilation during hospital admission
|
Duration of hospital stay, an expected average of 16 days
|
|
Receipt of cardiopulmonary resuscitation (CPR)
Time Frame: Duration of hospital stay, an expected average of 16 days
|
CPR prior to death or discharge
|
Duration of hospital stay, an expected average of 16 days
|
|
ICU mortality
Time Frame: Duration of hospital stay, an expected average of 16 days
|
ICU mortality
|
Duration of hospital stay, an expected average of 16 days
|
|
ICU length of stay
Time Frame: Duration of hospital stay, an expected average of 16 days
|
ICU length of stay (hours)
|
Duration of hospital stay, an expected average of 16 days
|
|
ICU readmission
Time Frame: Duration of hospital stay, an expected average of 16 days
|
Readmission to an ICU within the same hospitalization
|
Duration of hospital stay, an expected average of 16 days
|
|
Duration of mechanical ventilation
Time Frame: Duration of hospital stay, an expected average of 16 days
|
Hours of mechanical ventilation during hospital admission
|
Duration of hospital stay, an expected average of 16 days
|
|
Time to withdrawal of life-support
Time Frame: Duration of hospital stay, an expected average of 16 days
|
The number of hours from trial enrollment to time that comfort-care order is placed
|
Duration of hospital stay, an expected average of 16 days
|
|
Hospital discharge disposition
Time Frame: Duration of hospital stay, an expected average of 16 days
|
Hospital discharge disposition to home, hospice, long-term acute care, nursing facility, or rehabilitation
|
Duration of hospital stay, an expected average of 16 days
|
|
Quality of Dying & Death (1-item)
Time Frame: 48-72 hours following an in-hospital death
|
Nurse-reported postmortem rating of a patient's dying experience
|
48-72 hours following an in-hospital death
|
|
30-day hospital readmission
Time Frame: 30 days
|
30-day hospital readmission
|
30 days
|
|
90-day hospital readmission
Time Frame: 30 days
|
30-day hospital readmission
|
30 days
|
|
180-day hospital readmission
Time Frame: 30 days
|
30-day hospital readmission
|
30 days
|
|
30-day mortality
Time Frame: 30 days
|
Mortality rate at 30 days
|
30 days
|
|
90-day mortality
Time Frame: 90 days
|
Mortality rate at 90 days
|
90 days
|
|
180-day mortality
Time Frame: 180 days
|
Mortality rate at 180 days
|
180 days
|
|
Hospital free days
Time Frame: 180 days
|
Hospital free days within 180 days
|
180 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Scott D Halpern, PhD, MD, University of Pennsylvania
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 1, 2018
Primary Completion (ACTUAL)
April 24, 2021
Study Completion (ACTUAL)
June 30, 2022
Study Registration Dates
First Submitted
April 25, 2017
First Submitted That Met QC Criteria
May 1, 2017
First Posted (ACTUAL)
May 4, 2017
Study Record Updates
Last Update Posted (ACTUAL)
August 8, 2022
Last Update Submitted That Met QC Criteria
August 3, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UPenn IRB #826933
- 52635 (Patrick and Catherine Weldon Donaghue Foundation)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruitingDecision Making | Neonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Istituto Clinico HumanitasRecruitingCritical Illness Myopathy | Critical Illness Polyneuropathy | Critical Illness PolyneuromyopathyItaly
-
Yale UniversityNational Institute on Aging (NIA)RecruitingCritical Illness | Illness, CriticalUnited States
-
Assistance Publique - Hôpitaux de ParisEuropean Society of Intensive Care Medicine; French Society for Intensive Care and other collaboratorsRecruitingCritical Illness | Intensive Care Patients | Critical Illness Requiring Intensive Care - Sepsis | Critical Illness Requiring Intensive Care - Acute Brain Injury | Critical Illness Requiring Intensive Care - Major Surgery | Critical Illness Requiring Intensive Care - PolytraumaFrance
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Boston Children's HospitalCompleted
-
Istanbul Medeniyet UniversityRecruiting
-
Karolinska InstitutetNot yet recruitingPediatric Critical IllnessSweden
-
St Helens & Knowsley Teaching Hospitals NHS TrustManchester University NHS Foundation TrustCompleted
Clinical Trials on EHR-Based Intervention A
-
University of WashingtonNational Institute on Aging (NIA)CompletedLiver Cirrhosis | Neoplasm Metastasis | Pulmonary Disease, Chronic Obstructive | Dementia | Kidney Failure, Chronic | Chronic Disease | Peripheral Vascular Disease | Lung Diseases, Interstitial | Lung Neoplasm | Heart Failure,Congestive | Diabetes With End Organ InjuryUnited States
-
University of Pittsburgh Medical CenterCompletedBreast Cancer | Estrogen-receptor-positive Breast CancerUnited States
-
University of WashingtonNational Institute on Aging (NIA)CompletedLiver Cirrhosis | Lung Neoplasms | Neoplasm Metastasis | Pulmonary Disease, Chronic Obstructive | Dementia | Kidney Failure, Chronic | Chronic Disease | Peripheral Vascular Disease | Lung Diseases, Interstitial | Heart Failure, Congestive | Diabetes With End Organ InjuryUnited States
-
University of PennsylvaniaIndian Health Service (IHS)Completed
-
NYU Langone HealthNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Icahn School of Medicine at Mount SinaiNYC Health + HospitalsCompletedPotentially Inappropriate MedicationsUnited States
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Vanderbilt...CompletedChronic Kidney DiseasesUnited States
-
Thomas Jefferson UniversityWashington University School of Medicine; Northwestern UniversityRecruitingDiagnostic UncertaintyUnited States
-
NYU Langone HealthFood and Drug Administration (FDA)CompletedMedication Dosing ErrorUnited States
-
Chinese University of Hong KongNot yet recruitingWork Related Stress | Well-Being (Psychological Flourishing) | Work PerformanceHong Kong